Vivos Therapeutics, Inc. (VVOS)
USD 2.61
(1.56%)
USD 2.61
(1.56%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 352 Thousand USD | 131.83% |
| 2022 | -1.1 Million USD | 95.06% |
| 2021 | -22.39 Million USD | -32.41% |
| 2020 | -16.91 Million USD | -622.06% |
| 2019 | 3.24 Million USD | 670.28% |
| 2018 | -568.17 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -5.13 Million USD | -604.94% |
| 2024 Q1 | -729 Thousand USD | -307.1% |
| 2023 Q1 | -4.73 Million USD | -327.76% |
| 2023 Q2 | -1.73 Million USD | 63.41% |
| 2023 FY | 352 Thousand USD | 131.83% |
| 2023 Q4 | 352 Thousand USD | -68.46% |
| 2023 Q3 | 1.11 Million USD | 164.47% |
| 2022 Q1 | -15.62 Million USD | 30.26% |
| 2022 FY | -1.1 Million USD | 95.06% |
| 2022 Q4 | -1.1 Million USD | 71.44% |
| 2022 Q3 | -3.87 Million USD | 60.3% |
| 2022 Q2 | -9.75 Million USD | 37.56% |
| 2021 Q2 | -32.93 Million USD | -157.43% |
| 2021 FY | -22.39 Million USD | -32.41% |
| 2021 Q4 | -22.39 Million USD | 17.86% |
| 2021 Q3 | -27.26 Million USD | 17.2% |
| 2021 Q1 | -12.79 Million USD | 24.37% |
| 2020 FY | -16.91 Million USD | -622.06% |
| 2020 Q3 | -170.06 Thousand USD | -116.41% |
| 2020 Q2 | 1.03 Million USD | 120.82% |
| 2020 Q1 | 469.35 Thousand USD | -85.51% |
| 2020 Q4 | -16.91 Million USD | -9846.73% |
| 2019 Q4 | 3.24 Million USD | 0.0% |
| 2019 FY | 3.24 Million USD | 670.28% |
| 2018 FY | -568.17 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 98.7% |
| BrainsWay Ltd. | -10.32 Million USD | 103.411% |
| Cerus Corporation | 84.35 Million USD | 99.583% |
| Envoy Medical, Inc. | -3.81 Million USD | 109.229% |
| electroCore, Inc. | -9.95 Million USD | 103.536% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 106.868% |
| IceCure Medical Ltd | -9.93 Million USD | 103.543% |
| Inogen, Inc. | -103.56 Million USD | 100.34% |
| OrthoPediatrics Corp. | -9.26 Million USD | 103.798% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 109.668% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 102.688% |
| MaxCyte, Inc. | -27.76 Million USD | 101.268% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 106.851% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 161.136% |
| Orthofix Medical Inc. | 96.44 Million USD | 99.635% |
| PAVmed Inc | 29.08 Million USD | 98.79% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 102.078% |
| RxSight, Inc. | -6.68 Million USD | 105.269% |
| Sight Sciences, Inc. | -102.71 Million USD | 100.343% |
| SI-BONE, Inc. | 5.72 Million USD | 93.847% |
| TELA Bio, Inc. | -3.94 Million USD | 108.914% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 99.386% |
| Acutus Medical, Inc. | 12.27 Million USD | 97.133% |
| Talis Biomedical Corporation | -57.06 Million USD | 100.617% |
| Spectral AI, Inc. | -3.5 Million USD | 110.054% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 100.733% |
| CVRx, Inc. | -59.95 Million USD | 100.587% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 82.259% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 72.449% |
| Bioventus Inc. | 372.51 Million USD | 99.906% |
| Venus Concept Inc. | 74.3 Million USD | 99.526% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 103.457% |
| LivaNova PLC | 62.53 Million USD | 99.437% |
| 908 Devices Inc. | -115.09 Million USD | 100.306% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 99.89% |
| Nemaura Medical Inc. | 9.92 Million USD | 96.453% |
| NeuroPace, Inc. | 54.33 Million USD | 99.352% |
| LENSAR, Inc. | -18.31 Million USD | 101.922% |
| Apyx Medical Corporation | -5.15 Million USD | 106.834% |
| Cutera, Inc. | 288.3 Million USD | 99.878% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 95.316% |
| BioSig Technologies, Inc. | 262 Thousand USD | -34.351% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 100.803% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 103.827% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.975% |
| Axonics, Inc. | -77.19 Million USD | 100.456% |
| Outset Medical, Inc. | 67.67 Million USD | 99.48% |
| IRIDEX Corporation | -4.28 Million USD | 108.209% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 100.198% |
| IRadimed Corporation | -47.71 Million USD | 100.738% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 111.633% |
| INVO Bioscience, Inc. | 8.45 Million USD | 95.835% |
| Telesis Bio, Inc. | 32.63 Million USD | 98.921% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 114.068% |
| Varex Imaging Corporation | 316.9 Million USD | 99.889% |
| Quipt Home Medical Corp. | 81.73 Million USD | 99.569% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 112.653% |
| Pulmonx Corporation | -42.36 Million USD | 100.831% |
| Dynatronics Corporation | 6.2 Million USD | 94.326% |
| Modular Medical, Inc. | -8.04 Million USD | 104.377% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 108.192% |
| Semler Scientific, Inc. | -57.13 Million USD | 100.616% |
| InMode Ltd. | -135.39 Million USD | 100.26% |
| Bruker Corporation | 891.3 Million USD | 99.961% |
| Cytosorbents Corporation | 4.18 Million USD | 91.583% |
| DexCom, Inc. | 2.02 Billion USD | 99.983% |
| Align Technology, Inc. | -840.47 Million USD | 100.042% |
| Viveve Medical, Inc. | -13.81 Million USD | 102.548% |
| ZimVie Inc. | 450.41 Million USD | 99.922% |
| Movano Inc. | -5.86 Million USD | 106.001% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 100.262% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 161.136% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 82.259% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 99.901% |
| Profound Medical Corp. | -18.17 Million USD | 101.936% |
| Insulet Corporation | 798.1 Million USD | 99.956% |
| enVVeno Medical Corporation | -2.21 Million USD | 115.87% |
| Surmodics, Inc. | -12.01 Million USD | 102.93% |
| iCAD, Inc. | -21.2 Million USD | 101.66% |
| Nuwellis, Inc. | -2.81 Million USD | 112.487% |
| Biotricity, Inc. | 23.09 Million USD | 98.476% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 99.624% |
| Aethlon Medical, Inc. | -4.5 Million USD | 107.819% |
| InspireMD, Inc. | -8.04 Million USD | 104.375% |
| PAVmed Inc. | 29.08 Million USD | 98.79% |
| BIOLASE, Inc. | 11.34 Million USD | 96.897% |
| Beyond Air, Inc. | 6.22 Million USD | 94.349% |
| FONAR Corporation | -14.66 Million USD | 102.4% |
| AxoGen, Inc. | 32.26 Million USD | 98.909% |
| Vivani Medical, Inc. | 42 Thousand USD | -738.095% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 103.303% |
| Inari Medical, Inc. | -7.16 Million USD | 104.916% |
| UFP Technologies, Inc. | 40.77 Million USD | 99.137% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 88.529% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 107.377% |
| Tenon Medical, Inc. | -1.25 Million USD | 128.048% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 104.628% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 102.951% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.984% |
| Sintx Technologies, Inc. | 905 Thousand USD | 61.105% |
| NanoVibronix, Inc. | -3.27 Million USD | 110.738% |
| Quanterix Corporation | -132.95 Million USD | 100.265% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 112.653% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 101.574% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 99.953% |
| TransMedics Group, Inc. | 121.13 Million USD | 99.709% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 101.345% |
| NeuroMetrix, Inc. | -1.49 Million USD | 123.607% |
| Hyperfine, Inc. | -75.61 Million USD | 100.465% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 99.769% |
| Biomerica, Inc. | -3.38 Million USD | 110.399% |
| Bone Biologics Corporation | -3.02 Million USD | 111.63% |
| AVITA Medical, Inc. | -26.23 Million USD | 101.342% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 119.147% |
| Silk Road Medical, Inc | 64.42 Million USD | 99.454% |